Delek US Holdings

DKNYSEUSD

THESIS ALERT

Email me when the DK thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$68.41
+$1.25 (+1.86%)Today 1M −11.53%
After hours$69.40+1.45%

Updated Nov 12, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$67.16
Prior regular-session close from the quote source.
$66.92–$70.51
Regular-session low and high so far today.
1.1M
Regular-session shares traded · Nov 12, 4:00 PM ET.
Feb 26 projected
Projected for 2027-02-26 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
$25.85–$82.27
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own DK if Delek US is a cyclical refinery cash-flow recovery story whose equity value depends less on sales growth than on whether refining spreads and operating discipline can overcome a heavily levered balance sheet.

DK price history

Latest price$68.41Today+$1.25 (+1.86%)
DK -15.07%S&P 500 -2.67%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Delek’s refinery assets must keep capturing favorable crude-to-product spreads; the business does not need revenue growth if spread capture improves, but it does need margins that are structurally above the weak 2024 environment.StrengtheningMateriality: High

    GAAP annual gross_profit improved to $612.1 million in FY2025 from negative $43.1 million in FY2024. If spread capture holds, equity value can recover even on lower sales; if spreads structurally compress, revenue scale will not protect earnings.

    Watch: A sustained narrowing of WTI-Brent, light-heavy, or inland crude differentials would remove a key refining feedstock advantage.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual gross_profit improved to $612.1 million in FY2025 from negative $43.1 million in FY2024.

    Open source ↗
  • Because refining is fixed-asset and fixed-cost intensive, Delek must convert better spreads into operating income through high utilization, controlled turnaround costs, and reliable refinery operations.StrengtheningMateriality: High

    GAAP annual operating_income recovered to $301.0 million in FY2025 from a loss of $491.5 million in FY2024. If operating leverage works, modest margin improvement can materially lift earnings; if outages or costs absorb the spread, the equity remains impaired.

    Watch: Unplanned outages, fires, or extended maintenance at Delek refineries would prevent margin opportunities from reaching operating income.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual operating_income recovered to $301.0 million in FY2025 from a loss of $491.5 million in FY2024.

    Open source ↗
  • Delek’s investment case requires the refinery cycle to translate into operating cash flow, not just accounting profit, because working-capital swings and commodity inventories can dominate reported earnings.HoldingMateriality: Medium

    GAAP annual operating_cash_flow was $535.8 million in FY2025 after negative $66.8 million in FY2024. Positive operating cash flow gives Delek time to manage leverage and cyclicality; cash burn in a weak spread environment would quickly pressure the balance sheet.

    Watch: A crude-price spike that increases inventory and working-capital needs could consume cash before income statements show deterioration.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual operating_cash_flow was $535.8 million in FY2025 after negative $66.8 million in FY2024.

    Open source ↗
  • Delek’s balance sheet must not absorb the recovery; with liabilities large relative to book equity, debt service, refinancing, and other senior claims can prevent operating improvement from compounding to common shareholders.WeakeningMateriality: Medium

    Liabilities were $6.300 billion at FY2025 year-end versus equity of $547.3 million. If leverage is managed down or comfortably serviced, the equity has torque to a refining recovery; if leverage tightens, common shareholders bear disproportionate downside.

    Watch: A refinancing at materially higher rates would increase the claim of creditors on operating cash flow.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Liabilities were $6.300 billion at FY2025 year-end versus equity of $547.3 million.

    Open source ↗
  • The recovery must reach common-shareholder earnings, not stop at operating income; financing costs, taxes, minority interests, or other below-the-line claims cannot keep consuming refinery-level gains.HoldingMateriality: Medium

    GAAP annual net_income improved to a loss of $22.8 million in FY2025 from a loss of $560.4 million in FY2024. Operating improvement only creates per-share value if it survives below the operating line; otherwise the stock remains a high-risk cyclicality trade rather than an earnings compounder.

    Watch: Persistently high interest expense or refinancing costs would keep common-shareholder earnings negative despite operating profits.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual net_income improved to a loss of $22.8 million in FY2025 from a loss of $560.4 million in FY2024.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Delek’s refinery assets must keep capturing favorable crude-to-product spreads; the business does not need revenue growth if spread capture improves, but it does need margins that are structurally above the weak 2024 environment. If spread capture holds, equity value can recover even on lower sales; if spreads structurally compress, revenue scale will not protect earnings.

Because refining is fixed-asset and fixed-cost intensive, Delek must convert better spreads into operating income through high utilization, controlled turnaround costs, and reliable refinery operations. If operating leverage works, modest margin improvement can materially lift earnings; if outages or costs absorb the spread, the equity remains impaired.

Delek’s investment case requires the refinery cycle to translate into operating cash flow, not just accounting profit, because working-capital swings and commodity inventories can dominate reported earnings. Positive operating cash flow gives Delek time to manage leverage and cyclicality; cash burn in a weak spread environment would quickly pressure the balance sheet.

Delek’s balance sheet must not absorb the recovery; with liabilities large relative to book equity, debt service, refinancing, and other senior claims can prevent operating improvement from compounding to common shareholders. If leverage is managed down or comfortably serviced, the equity has torque to a refining recovery; if leverage tightens, common shareholders bear disproportionate downside.

The recovery must reach common-shareholder earnings, not stop at operating income; financing costs, taxes, minority interests, or other below-the-line claims cannot keep consuming refinery-level gains. Operating improvement only creates per-share value if it survives below the operating line; otherwise the stock remains a high-risk cyclicality trade rather than an earnings compounder.

All standing thesis claims
Original report summary

Delek US is a cyclical refinery cash-flow recovery story whose equity value depends less on sales growth than on whether refining spreads and operating discipline can overcome a heavily levered balance sheet.

Evidence assessed Nov 12, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Delek US Holdings

Where the evidence on Delek US Holdings disagrees: Mixed on the latest evidence (Nov 12, 2026). Of its 5 thesis points, 2 strengthening, 2 holding and 1 weakening.

Bull case: what the evidence supports

  • Delek’s refinery assets must keep capturing favorable crude-to-product spreads; the business does not need revenue growth if spread capture improves, but it does need margins that are structurally above the weak 2024 environment.

    sec.gov ↗

  • Because refining is fixed-asset and fixed-cost intensive, Delek must convert better spreads into operating income through high utilization, controlled turnaround costs, and reliable refinery operations.

    sec.gov ↗

  • Delek’s investment case requires the refinery cycle to translate into operating cash flow, not just accounting profit, because working-capital swings and commodity inventories can dominate reported earnings.

    sec.gov ↗

  • The recovery must reach common-shareholder earnings, not stop at operating income; financing costs, taxes, minority interests, or other below-the-line claims cannot keep consuming refinery-level gains.

    sec.gov ↗

Bear case: what the evidence questions

  • Delek’s balance sheet must not absorb the recovery; with liabilities large relative to book equity, debt service, refinancing, and other senior claims can prevent operating improvement from compounding to common shareholders.

    sec.gov ↗

Thesis-Break Engine

What has broken in Delek US Holdings’s thesis

Each break OptimistFi flagged on Delek US Holdings, dated — with what has historically followed the same kind of break across the market, not a forecast for Delek US Holdings.

  • Sharp drawdowncondition set before this filing

    Across all companies, this kind of break has happened 15,428 times before. Those stocks beat comparable companies by a median of 1% over the next six months, and 33% of them trailed it by 10 points or more.

  • Price target fell below the stockcondition set before this filing

    Across all companies, this kind of break has happened 1,809 times before. Those stocks trailed comparable companies by a median of 1% over the next six months, and 33% of them trailed it by 10 points or more.

  • Insider-selling clustercondition set before this filing

    Across all companies, this kind of break has happened 9,137 times before. Those stocks beat comparable companies by a median of 1% over the next six months, and 30% of them trailed it by 10 points or more.

Several kinds of break have stacked on Delek US Holdings at once. A cluster is a stronger read than any one signal alone.

How the Thesis-Break Engine works →Historical outcomes are measured against comparable companies after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Reported results of operations (earnings release).

    Delek US Holdings filed an SEC 8-K on 2026-11-06: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  2. Mixed
    Other material event.

    Delek US Holdings filed an SEC 8-K on 2026-10-29: Other material event. It is a dated development that tests the current thesis.

  3. Mixed
    Entered a material definitive agreement.

    Delek US Holdings filed an SEC 8-K on 2026-09-29: Entered a material definitive agreement. It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • A sustained narrowing of WTI-Brent, light-heavy, or inland crude differentials would remove a key refining feedstock advantage.
  • Unplanned outages, fires, or extended maintenance at Delek refineries would prevent margin opportunities from reaching operating income.
  • A crude-price spike that increases inventory and working-capital needs could consume cash before income statements show deterioration.
  • A refinancing at materially higher rates would increase the claim of creditors on operating cash flow.
  • Persistently high interest expense or refinancing costs would keep common-shareholder earnings negative despite operating profits.

DK news

Loading headlines…

Financial statements

DK income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

DK: quick answers

When does Delek US Holdings (DK) report earnings next?
Delek US Holdings's next results are projected for February 26, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on November 6, 2026. Earnings calendar
What is DK's short interest?
As of October 30, 2026, 7.5M DK shares were sold short, 12.3% of its shares outstanding, up 4.3% from the count before. At the stock's average daily volume that is 4.3 days to cover. FINRA publishes the count twice a month. DK short interest history
ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.